Evidence map›Paper›PMID 37977868›Full record

ArticleBMJ open2023

Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study.

Lindy Dickson, Sacha Roxanne Le Roux, Leila Mitrani, Jeremy Hill, Waasila Jassat, Helen Cox, Koleka Mlisana, John Black, Marian Loveday, Alison Grant and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Lindy DicksonDivision of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Sacha Roxanne Le RouxDivision of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-0020-1414
Leila MitraniDivision of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Jeremy HillTB Centre, London School of Hygiene &Tropical Medicine, London, UK.
Waasila JassatSchool of Public Health, University of the Western Cape, Bellville, South Africa.
Helen CoxDivision of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-6538-7192
Koleka MlisanaSchool of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal College of Health Sciences, Durban, KwaZulu-Natal, South Africa.
John BlackDivision of Infectious Diseases, University of Cape Town, Cape Town, South Africa.
Marian LovedaySouth African Medical Research Council, Durban, South Africa.ORCID 0000-0001-9205-9314
Alison GrantTB Centre, London School of Hygiene &Tropical Medicine, London, UK.
Karina KielmannInstitute of Tropical Medicine, Antwerp, Belgium.
Norbert NdjekaNational Tuberculosis Control Programme, National Department of Health, Pretoria, South Africa.ORCID 0000-0001-6200-1592
Mosa MoshabelaSchool of Nursing and Public Health, University of KwaZulu-Natal College of Health Sciences, Durban, KwaZulu-Natal, South Africa.
Mark NicolDivision of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa Mark.Nicol@uwa.edu.au.ORCID 0000-0002-1366-4805
University of Cape Town · ZALondon School of Hygiene & Tropical Medicine · GBUniversity of KwaZulu-Natal · ZADepartment of Health · ZAQueen Margaret University · GBSouth African Medical Research Council · ZAUniversity of the Western Cape · ZA

Funding

Medical Research Council MR/N015924/1Wellcome Trust
6 · The paper itself

Abstract

objectivesTreatment for multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is increasingly transitioning from hospital-centred to community-based care. A national policy for decentralised programmatic MDR/RR-TB care was adopted in South Africa in 2011. We explored variations in the implementation of care models in response to this change in policy, and the implications of these variations for people affected by MDR/RR-TB.

designA mixed methods study was done of patient movements between healthcare facilities, reconstructed from laboratory records. Facility visits and staff interviews were used to determine reasons for movements. PARTICIPANTS AND

settingPeople identified with MDR/RR-TB from 13 high-burden districts within South Africa. OUTCOME MEASURES: Geospatial movement patterns were used to identify organisational models. Reasons for patient movement and implications of different organisational models for people affected by MDR/RR-TB and the health system were determined.

resultsAmong 191 participants, six dominant geospatial movement patterns were identified, which varied in average hospital stay (0-281 days), average patient distance travelled (12-198 km) and number of health facilities involved in care (1-5 facilities). More centralised models were associated with longer delays to treatment initiation and lengthy hospitalisation. Decentralised models facilitated family-centred care and were associated with reduced time to treatment and hospitalisation duration. Responsiveness to the needs of people affected by MDR/RR-TB and health system constraints was achieved through implementation of flexible models, or the implementation of multiple models in a district.

conclusionsUnderstanding how models for organising care have evolved may assist policy implementers to tailor implementation to promote particular patterns of care organisation or encourage flexibility, based on patient needs and local health system resources. Our approach can contribute towards the development of a health systems typology for understanding how policy-driven models of service delivery are implemented in the context of variable resources.

Indexed as

Antitubercular AgentsTuberculosis, Multidrug-ResistantHospitalizationHumansRifampinSouth AfricaAntitubercular AgentsRifampinHealth policyOrganisation of health servicesPatient-Centered CarePUBLIC HEALTHQUALITATIVE RESEARCHTuberculosis

Identifiers

PMID37977868
PMCPMC10660906
OpenAlexW4388783667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.